COVID-19 Outbreak-Global Neurological Biomarkers Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience, and cardiovascular disease.
The Neurological Biomarkers market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Neurological Biomarkers industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Neurological Biomarkers market can be split based on product types, major applications, and important countries as follows:
Key players in the global Neurological Biomarkers market covered in Chapter 12:
Proteome Sciences
Athena Diagnostics
Aepodia
Quanterix
Myriad RBM
Cisbio Bioassays
AbaStar MDx
ImmunArray
Thermo Fisher Scientific
Abiant
Acumen Pharmaceuticals
QIAGEN
In Chapter 4 and 14.1, on the basis of types, the Neurological Biomarkers market from 2015 to 2025 is primarily split into:
Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
In Chapter 5 and 14.2, on the basis of applications, the Neurological Biomarkers market from 2015 to 2025 covers:
Hospitals
Clinics
Diagnostic and research laboratories
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Neurological Biomarkers Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Neurological Biomarkers
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Neurological Biomarkers industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Neurological Biomarkers Market Size, 2015 – 2020
2.1.2 Global Neurological Biomarkers Market Size by Type, 2015 – 2020
2.1.3 Global Neurological Biomarkers Market Size by Application, 2015 – 2020
2.1.4 Global Neurological Biomarkers Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Neurological Biomarkers Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Neurological Biomarkers Analysis
3.2 Major Players of Neurological Biomarkers
3.3 Neurological Biomarkers Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Neurological Biomarkers
3.3.3 Labor Cost of Neurological Biomarkers
3.4 Market Distributors of Neurological Biomarkers
3.5 Major Downstream Buyers of Neurological Biomarkers Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Neurological Biomarkers Market, by Type
4.1 Global Neurological Biomarkers Value and Market Share by Type (2015-2020)
4.2 Global Neurological Biomarkers Production and Market Share by Type (2015-2020)
4.3 Global Neurological Biomarkers Value and Growth Rate by Type (2015-2020)
4.3.1 Global Neurological Biomarkers Value and Growth Rate of Alzheimer's disease (AD)
4.3.2 Global Neurological Biomarkers Value and Growth Rate of Multiple sclerosis (MS)
4.3.3 Global Neurological Biomarkers Value and Growth Rate of Parkinson's disease (PD)
4.3.4 Global Neurological Biomarkers Value and Growth Rate of Autism spectrum disorder (ASD)
4.4 Global Neurological Biomarkers Price Analysis by Type (2015-2020)
5 Neurological Biomarkers Market, by Application
5.1 Downstream Market Overview
5.2 Global Neurological Biomarkers Consumption and Market Share by Application (2015-2020)
5.3 Global Neurological Biomarkers Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2015-2020)
5.3.2 Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2015-2020)
5.3.3 Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2015-2020)
6 Global Neurological Biomarkers Market Analysis by Regions
6.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
6.1.1 Global Neurological Biomarkers Sales by Regions (2015-2020)
6.1.2 Global Neurological Biomarkers Revenue by Regions (2015-2020)
6.2 North America Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.3 Europe Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.6 South America Neurological Biomarkers Sales and Growth Rate (2015-2020)
7 North America Neurological Biomarkers Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Neurological Biomarkers Sales, Revenue and Market Share by Countries
7.2.1 North America Neurological Biomarkers Sales by Countries (2015-2020)
7.2.2 North America Neurological Biomarkers Revenue by Countries (2015-2020)
7.3 United States Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.4 Canada Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.5 Mexico Neurological Biomarkers Sales and Growth Rate (2015-2020)
8 Europe Neurological Biomarkers Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries
8.2.1 Europe Neurological Biomarkers Sales by Countries (2015-2020)
8.2.2 Europe Neurological Biomarkers Revenue by Countries (2015-2020)
8.3 Germany Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.4 UK Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.5 France Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.6 Italy Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.7 Spain Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.8 Russia Neurological Biomarkers Sales and Growth Rate (2015-2020)
9 Asia Pacific Neurological Biomarkers Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Neurological Biomarkers Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Neurological Biomarkers Sales by Countries (2015-2020)
9.2.2 Asia Pacific Neurological Biomarkers Revenue by Countries (2015-2020)
9.3 China Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.4 Japan Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.5 South Korea Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.6 India Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.8 Australia Neurological Biomarkers Sales and Growth Rate (2015-2020)
10 Middle East and Africa Neurological Biomarkers Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Neurological Biomarkers Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Neurological Biomarkers Revenue by Countries (2015-2020)
10.3 Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2015-2020)
10.4 UAE Neurological Biomarkers Sales and Growth Rate (2015-2020)
10.5 Egypt Neurological Biomarkers Sales and Growth Rate (2015-2020)
10.6 Nigeria Neurological Biomarkers Sales and Growth Rate (2015-2020)
10.7 South Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
11 South America Neurological Biomarkers Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Neurological Biomarkers Sales, Revenue and Market Share by Countries
11.2.1 South America Neurological Biomarkers Sales by Countries (2015-2020)
11.2.2 South America Neurological Biomarkers Revenue by Countries (2015-2020)
11.3 Brazil Neurological Biomarkers Sales and Growth Rate (2015-2020)
11.4 Argentina Neurological Biomarkers Sales and Growth Rate (2015-2020)
11.5 Columbia Neurological Biomarkers Sales and Growth Rate (2015-2020)
11.6 Chile Neurological Biomarkers Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Proteome Sciences
12.1.1 Proteome Sciences Basic Information
12.1.2 Neurological Biomarkers Product Introduction
12.1.3 Proteome Sciences Production, Value, Price, Gross Margin 2015-2020
12.2 Athena Diagnostics
12.2.1 Athena Diagnostics Basic Information
12.2.2 Neurological Biomarkers Product Introduction
12.2.3 Athena Diagnostics Production, Value, Price, Gross Margin 2015-2020
12.3 Aepodia
12.3.1 Aepodia Basic Information
12.3.2 Neurological Biomarkers Product Introduction
12.3.3 Aepodia Production, Value, Price, Gross Margin 2015-2020
12.4 Quanterix
12.4.1 Quanterix Basic Information
12.4.2 Neurological Biomarkers Product Introduction
12.4.3 Quanterix Production, Value, Price, Gross Margin 2015-2020
12.5 Myriad RBM
12.5.1 Myriad RBM Basic Information
12.5.2 Neurological Biomarkers Product Introduction
12.5.3 Myriad RBM Production, Value, Price, Gross Margin 2015-2020
12.6 Cisbio Bioassays
12.6.1 Cisbio Bioassays Basic Information
12.6.2 Neurological Biomarkers Product Introduction
12.6.3 Cisbio Bioassays Production, Value, Price, Gross Margin 2015-2020
12.7 AbaStar MDx
12.7.1 AbaStar MDx Basic Information
12.7.2 Neurological Biomarkers Product Introduction
12.7.3 AbaStar MDx Production, Value, Price, Gross Margin 2015-2020
12.8 ImmunArray
12.8.1 ImmunArray Basic Information
12.8.2 Neurological Biomarkers Product Introduction
12.8.3 ImmunArray Production, Value, Price, Gross Margin 2015-2020
12.9 Thermo Fisher Scientific
12.9.1 Thermo Fisher Scientific Basic Information
12.9.2 Neurological Biomarkers Product Introduction
12.9.3 Thermo Fisher Scientific Production, Value, Price, Gross Margin 2015-2020
12.10 Abiant
12.10.1 Abiant Basic Information
12.10.2 Neurological Biomarkers Product Introduction
12.10.3 Abiant Production, Value, Price, Gross Margin 2015-2020
12.11 Acumen Pharmaceuticals
12.11.1 Acumen Pharmaceuticals Basic Information
12.11.2 Neurological Biomarkers Product Introduction
12.11.3 Acumen Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.12 QIAGEN
12.12.1 QIAGEN Basic Information
12.12.2 Neurological Biomarkers Product Introduction
12.12.3 QIAGEN Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Neurological Biomarkers Market Forecast
14.1 Global Neurological Biomarkers Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Alzheimer's disease (AD) Market Value and Volume Forecast (2020-2025)
14.1.2 Multiple sclerosis (MS) Market Value and Volume Forecast (2020-2025)
14.1.3 Parkinson's disease (PD) Market Value and Volume Forecast (2020-2025)
14.1.4 Autism spectrum disorder (ASD) Market Value and Volume Forecast (2020-2025)
14.2 Global Neurological Biomarkers Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
14.2.2 Clinics Market Value and Volume Forecast (2020-2025)
14.2.3 Diagnostic and research laboratories Market Value and Volume Forecast (2020-2025)
14.3 Neurological Biomarkers Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Neurological Biomarkers
Table Product Specification of Neurological Biomarkers
Table Neurological Biomarkers Key Market Segments
Table Key Players Neurological Biomarkers Covered
Figure Global Neurological Biomarkers Market Size, 2015 – 2025
Table Different Types of Neurological Biomarkers
Figure Global Neurological Biomarkers Value ($) Segment by Type from 2015-2020
Figure Global Neurological Biomarkers Market Share by Types in 2019
Table Different Applications of Neurological Biomarkers
Figure Global Neurological Biomarkers Value ($) Segment by Applications from 2015-2020
Figure Global Neurological Biomarkers Market Share by Applications in 2019
Figure Global Neurological Biomarkers Market Share by Regions in 2019
Figure North America Neurological Biomarkers Production Value ($) and Growth Rate (2015-2020)
Figure Europe Neurological Biomarkers Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Neurological Biomarkers Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Neurological Biomarkers Production Value ($) and Growth Rate (2015-2020)
Figure South America Neurological Biomarkers Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Neurological Biomarkers
Table Upstream Raw Material Suppliers of Neurological Biomarkers with Contact Information
Table Major Players Headquarters, and Service Area of Neurological Biomarkers
Figure Major Players Production Value Market Share of Neurological Biomarkers in 2019
Table Major Players Neurological Biomarkers Product Types in 2019
Figure Production Process of Neurological Biomarkers
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Channel Status of Neurological Biomarkers
Table Major Distributors of Neurological Biomarkers with Contact Information
Table Major Downstream Buyers of Neurological Biomarkers with Contact Information
Table Global Neurological Biomarkers Value ($) by Type (2015-2020)
Table Global Neurological Biomarkers Value Share by Type (2015-2020)
Figure Global Neurological Biomarkers Value Share by Type (2015-2020)
Table Global Neurological Biomarkers Production by Type (2015-2020)
Table Global Neurological Biomarkers Production Share by Type (2015-2020)
Figure Global Neurological Biomarkers Production Share by Type (2015-2020)
Figure Global Neurological Biomarkers Value ($) and Growth Rate of Alzheimer's disease (AD) (2015-2020)
Figure Global Neurological Biomarkers Value ($) and Growth Rate of Multiple sclerosis (MS) (2015-2020)
Figure Global Neurological Biomarkers Value ($) and Growth Rate of Parkinson's disease (PD) (2015-2020)
Figure Global Neurological Biomarkers Value ($) and Growth Rate of Autism spectrum disorder (ASD) (2015-2020)
Figure Global Neurological Biomarkers Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Neurological Biomarkers Consumption by Application (2015-2020)
Table Global Neurological Biomarkers Consumption Market Share by Application (2015-2020)
Figure Global Neurological Biomarkers Consumption Market Share by Application (2015-2020)
Figure Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2015-2020)
Figure Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2015-2020)
Figure Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2015-2020)
Figure Global Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Global Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table Global Neurological Biomarkers Sales by Regions (2015-2020)
Table Global Neurological Biomarkers Sales Market Share by Regions (2015-2020)
Table Global Neurological Biomarkers Revenue (M USD) by Regions (2015-2020)
Table Global Neurological Biomarkers Revenue Market Share by Regions (2015-2020)
Table Global Neurological Biomarkers Revenue Market Share by Regions in 2015
Table Global Neurological Biomarkers Revenue Market Share by Regions in 2019
Figure North America Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Europe Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure South America Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table North America Neurological Biomarkers Sales by Countries (2015-2020)
Table North America Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table North America Neurological Biomarkers Revenue (M USD) by Countries (2015-2020)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure United States Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Canada Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Mexico Neurological Biomarkers Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table Europe Neurological Biomarkers Sales by Countries (2015-2020)
Table Europe Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table Europe Neurological Biomarkers Revenue (M USD) by Countries (2015-2020)
Table Europe Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure Germany Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure UK Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure France Neurological Biomarkers Sales and Growth (2015-2020)
Figure Italy Neurological Biomarkers Sales and Growth (2015-2020)
Figure Spain Neurological Biomarkers Sales and Growth (2015-2020)
Figure Russia Neurological Biomarkers Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Neurological Biomarkers Sales by Countries (2015-2020)
Table Asia Pacific Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table Asia Pacific Neurological Biomarkers Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure China Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Japan Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure South Korea Neurological Biomarkers Sales and Growth (2015-2020)
Figure India Neurological Biomarkers Sales and Growth (2015-2020)
Figure Southeast Asia Neurological Biomarkers Sales and Growth (2015-2020)
Figure Australia Neurological Biomarkers Sales and Growth (2015-2020)
Figure Middle East Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table Middle East Neurological Biomarkers Sales by Countries (2015-2020)
Table Middle East and Africa Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Neurological Biomarkers Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure UAE Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Egypt Neurological Biomarkers Sales and Growth (2015-2020)
Figure Nigeria Neurological Biomarkers Sales and Growth (2015-2020)
Figure South Africa Neurological Biomarkers Sales and Growth (2015-2020)
Figure South America Neurological Biomarkers Revenue (M USD) and Growth (2015-2020)
Table South America Neurological Biomarkers Sales by Countries (2015-2020)
Table South America Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table South America Neurological Biomarkers Revenue (M USD) by Countries (2015-2020)
Table South America Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure Brazil Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Argentina Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure Columbia Neurological Biomarkers Sales and Growth (2015-2020)
Figure Chile Neurological Biomarkers Sales and Growth (2015-2020)
Figure Top 3 Market Share of Neurological Biomarkers Companies in 2019
Figure Top 6 Market Share of Neurological Biomarkers Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Proteome Sciences Profile
Table Proteome Sciences Product Introduction
Figure Proteome Sciences Production and Growth Rate
Figure Proteome Sciences Value ($) Market Share 2015-2020
Table Athena Diagnostics Profile
Table Athena Diagnostics Product Introduction
Figure Athena Diagnostics Production and Growth Rate
Figure Athena Diagnostics Value ($) Market Share 2015-2020
Table Aepodia Profile
Table Aepodia Product Introduction
Figure Aepodia Production and Growth Rate
Figure Aepodia Value ($) Market Share 2015-2020
Table Quanterix Profile
Table Quanterix Product Introduction
Figure Quanterix Production and Growth Rate
Figure Quanterix Value ($) Market Share 2015-2020
Table Myriad RBM Profile
Table Myriad RBM Product Introduction
Figure Myriad RBM Production and Growth Rate
Figure Myriad RBM Value ($) Market Share 2015-2020
Table Cisbio Bioassays Profile
Table Cisbio Bioassays Product Introduction
Figure Cisbio Bioassays Production and Growth Rate
Figure Cisbio Bioassays Value ($) Market Share 2015-2020
Table AbaStar MDx Profile
Table AbaStar MDx Product Introduction
Figure AbaStar MDx Production and Growth Rate
Figure AbaStar MDx Value ($) Market Share 2015-2020
Table ImmunArray Profile
Table ImmunArray Product Introduction
Figure ImmunArray Production and Growth Rate
Figure ImmunArray Value ($) Market Share 2015-2020
Table Thermo Fisher Scientific Profile
Table Thermo Fisher Scientific Product Introduction
Figure Thermo Fisher Scientific Production and Growth Rate
Figure Thermo Fisher Scientific Value ($) Market Share 2015-2020
Table Abiant Profile
Table Abiant Product Introduction
Figure Abiant Production and Growth Rate
Figure Abiant Value ($) Market Share 2015-2020
Table Acumen Pharmaceuticals Profile
Table Acumen Pharmaceuticals Product Introduction
Figure Acumen Pharmaceuticals Production and Growth Rate
Figure Acumen Pharmaceuticals Value ($) Market Share 2015-2020
Table QIAGEN Profile
Table QIAGEN Product Introduction
Figure QIAGEN Production and Growth Rate
Figure QIAGEN Value ($) Market Share 2015-2020
Table Market Driving Factors of Neurological Biomarkers
Table Merger, Acquisition and New Investment
Table Global Neurological Biomarkers Market Value ($) Forecast, by Type
Table Global Neurological Biomarkers Market Volume Forecast, by Type
Figure Global Neurological Biomarkers Market Value ($) and Growth Rate Forecast of Alzheimer's disease (AD) (2020-2025)
Figure Global Neurological Biomarkers Market Volume ($) and Growth Rate Forecast of Alzheimer's disease (AD) (2020-2025)
Figure Global Neurological Biomarkers Market Value ($) and Growth Rate Forecast of Multiple sclerosis (MS) (2020-2025)
Figure Global Neurological Biomarkers Market Volume ($) and Growth Rate Forecast of Multiple sclerosis (MS) (2020-2025)
Figure Global Neurological Biomarkers Market Value ($) and Growth Rate Forecast of Parkinson's disease (PD) (2020-2025)
Figure Global Neurological Biomarkers Market Volume ($) and Growth Rate Forecast of Parkinson's disease (PD) (2020-2025)
Figure Global Neurological Biomarkers Market Value ($) and Growth Rate Forecast of Autism spectrum disorder (ASD) (2020-2025)
Figure Global Neurological Biomarkers Market Volume ($) and Growth Rate Forecast of Autism spectrum disorder (ASD) (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Clinics (2020-2025)
Figure Market Volume and Growth Rate Forecast of Clinics (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Diagnostic and research laboratories (2020-2025)
Figure Market Volume and Growth Rate Forecast of Diagnostic and research laboratories (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Research Methodology:
Neurological Biomarkers Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|